Victrex (VCT) Competitors GBX 797 -9.00 (-1.12%) As of 06:02 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock VCT vs. JMAT, ELM, SCPA, ESNT, TET, SYNT, ZTF, IOF, WCH, and ITXShould you be buying Victrex stock or one of its competitors? The main competitors of Victrex include Johnson Matthey (JMAT), Elementis (ELM), Scapa Group (SCPA), Essentra (ESNT), Treatt (TET), Synthomer (SYNT), Zotefoams (ZTF), Iofina (IOF), Wilmcote Holdings plc (WCH.L) (WCH), and Itaconix (ITX). These companies are all part of the "specialty chemicals" industry. Victrex vs. Johnson Matthey Elementis Scapa Group Essentra Treatt Synthomer Zotefoams Iofina Wilmcote Holdings plc (WCH.L) Itaconix Victrex (LON:VCT) and Johnson Matthey (LON:JMAT) are both basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, community ranking, profitability, institutional ownership, media sentiment, earnings, dividends and analyst recommendations. Is VCT or JMAT a better dividend stock? Victrex pays an annual dividend of GBX 60 per share and has a dividend yield of 7.4%. Johnson Matthey pays an annual dividend of GBX 77 per share and has a dividend yield of 6.4%. Victrex pays out 170.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Johnson Matthey pays out 130.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Which has more risk and volatility, VCT or JMAT? Victrex has a beta of 0.69, meaning that its stock price is 31% less volatile than the S&P 500. Comparatively, Johnson Matthey has a beta of 0.95, meaning that its stock price is 5% less volatile than the S&P 500. Do analysts rate VCT or JMAT? Victrex currently has a consensus price target of GBX 1,170, suggesting a potential upside of 45.16%. Johnson Matthey has a consensus price target of GBX 1,900, suggesting a potential upside of 58.33%. Given Johnson Matthey's stronger consensus rating and higher possible upside, analysts clearly believe Johnson Matthey is more favorable than Victrex.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Victrex 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Johnson Matthey 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Does the MarketBeat Community believe in VCT or JMAT? Victrex received 21 more outperform votes than Johnson Matthey when rated by MarketBeat users. Likewise, 63.61% of users gave Victrex an outperform vote while only 61.99% of users gave Johnson Matthey an outperform vote. CompanyUnderperformOutperformVictrexOutperform Votes50763.61% Underperform Votes29036.39% Johnson MattheyOutperform Votes48661.99% Underperform Votes29838.01% Do institutionals & insiders have more ownership in VCT or JMAT? 97.1% of Victrex shares are held by institutional investors. Comparatively, 66.6% of Johnson Matthey shares are held by institutional investors. 1.6% of Victrex shares are held by company insiders. Comparatively, 0.6% of Johnson Matthey shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has better earnings and valuation, VCT or JMAT? Johnson Matthey has higher revenue and earnings than Victrex. Johnson Matthey is trading at a lower price-to-earnings ratio than Victrex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVictrex£285.02M2.47£30.80M£35.2022.90Johnson Matthey£11.69B0.17£98.34M£58.8520.39 Does the media favor VCT or JMAT? In the previous week, Victrex and Victrex both had 1 articles in the media. Johnson Matthey's average media sentiment score of 2.00 beat Victrex's score of -0.98 indicating that Johnson Matthey is being referred to more favorably in the news media. Company Overall Sentiment Victrex Negative Johnson Matthey Very Positive Is VCT or JMAT more profitable? Victrex has a net margin of 10.81% compared to Johnson Matthey's net margin of 0.84%. Victrex's return on equity of 6.67% beat Johnson Matthey's return on equity.Company Net Margins Return on Equity Return on Assets Victrex10.81% 6.67% 6.59% Johnson Matthey 0.84%4.49%3.41% SummaryVictrex beats Johnson Matthey on 10 of the 19 factors compared between the two stocks. Remove Ads Get Victrex News Delivered to You Automatically Sign up to receive the latest news and ratings for VCT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VCT vs. The Competition Export to ExcelMetricVictrexSpecialty Chemicals IndustryMaterials SectorLON ExchangeMarket Cap£703.09M£8.07B£2.96B£2.46BDividend Yield6.22%3.58%5.23%4.95%P/E Ratio22.9012.2277.20131.24Price / Sales2.4747.5424,272,056,611,966,700.00260,214.95Price / Cash34.2119.2524.3227.94Price / Book1.525.055.194.45Net Income£30.80M£220.83M£154.96M£5.79B7 Day Performance9.36%2.60%5.26%5.49%1 Month Performance-17.08%4.80%2.40%4.07%1 Year Performance-35.21%-19.25%15.94%102.00% Victrex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VCTVictrex2.2599 of 5 starsGBX 797-1.1%GBX 1,170+46.8%-37.1%£695.24M£285.02M22.641,109Dividend IncreaseNegative NewsGap DownJMATJohnson Matthey3.7014 of 5 starsGBX 1,164-4.7%GBX 1,900+63.2%-33.2%£1.95B£11.69B19.78N/AHigh Trading VolumeELMElementis1.7873 of 5 starsGBX 115-5.6%GBX 170+47.8%-15.0%£848.98M£919.45M-24.401,281Negative NewsGap DownSCPAScapa GroupN/AN/AN/AN/A£402.98M£281.80M-7.321,461ESNTEssentra2.4146 of 5 starsGBX 92.63-2.6%GBX 206.67+123.1%-48.4%£266.26M£309.74M76.31350Negative NewsTETTreatt2.8168 of 5 starsGBX 319-3.3%GBX 650+103.8%-54.4%£192.87M£142.31M17.24350Dividend IncreaseGap DownHigh Trading VolumeSYNTSynthomer2.1517 of 5 starsGBX 84-10.6%GBX 225+167.9%-67.7%£137.74M£1.87B-1.684,200Negative NewsGap DownHigh Trading VolumeZTFZotefoamsN/AGBX 229-8.0%N/A-36.0%£110.14M£131.66M11.09549Gap DownHigh Trading VolumeIOFIofina2.3887 of 5 starsGBX 21-2.9%GBX 36.25+72.6%-14.2%£50.42M£61.34M14.7495Gap DownWCHWilmcote Holdings plc (WCH.L)N/AN/AN/AN/A£20.13MN/A-5.003ITXItaconixN/AGBX 109.48-4.6%N/A-33.5%£14.76M£5.28M-9.9117Gap Down Remove Ads Related Companies and Tools Related Companies Johnson Matthey Alternatives Elementis Alternatives Scapa Group Alternatives Essentra Alternatives Treatt Alternatives Synthomer Alternatives Zotefoams Alternatives Iofina Alternatives Wilmcote Holdings plc (WCH.L) Alternatives Itaconix Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:VCT) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredRadical shift coming to the stock market (read this ASAP)This is an urgent warning for all American investors … In a matter of days, we could see a radical shift in...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMusk's panic move: What the world's richest man fears is comingWhether you have modest savings of $10,000 or substantial wealth of $10 million, this information could determ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Victrex plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Victrex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.